Wells Fargo Upgrades United Therapeutics to Overweight, Raises Price Target to $738
Benzinga Newsdesk 5 months ago
NewsUpgradesPrice TargetAnalyst Ratings
Wells Fargo analyst Benjamin Burnett upgrades United Therapeutics (NASDAQ:UTHR) from Equal-Weight to Overweight and raises the price target from $575 to $738.
Wells Fargo analyst Benjamin Burnett upgrades United Therapeutics (NASDAQ:UTHR) from Equal-Weight to Overweight and raises the price target from $575 to $738.